Delivery Order SPE2DR25D1053-SPE2DR26FU059
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Dorzolamide-Timolol eye drops in 10ml units, with a contract ceiling value of $2,224.32. This non-set-aside, firm fixed-price delivery order is scheduled for completion by September 11, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal...
- The Defense Logistics Agency awarded a $1,110.96 delivery order to AmerisourceBergen Drug Corp for Dorzolamide-Timolol eye drops (10ml) on August 15, 2025, with an ultimate completion date of August 18, 2025. The contract represents a firm fixed price delivery order with no set-aside designation, indicating the award was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a $9,144.21 firm fixed price delivery order to AmerisourceBergen Drug Corp for Dorzolamide-Timolol eye drops (10ml) on October 27, 2025, with an ultimate completion date of October 28, 2025. The order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $1,446.16 to AmerisourceBergen Drug Corp for Dorzolamide-Timolol eye drops (10ml) on July 24, 2025, with an ultimate completion date of July 25, 2025. This contract uses firm fixed pricing and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military...
- The Defense Logistics Agency awarded a delivery order valued at $1,813.11 to AmerisourceBergen Drug Corp for the supply of Dorzolamide-Timolol Eye Drops (10ml) on November 10, 2025, with an ultimate completion date of November 12, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Dorzolamide-Timolol eye drops (10ml) with a contract ceiling value of $1,318.75. This is a firm fixed-price delivery order with an ultimate completion date of August 22, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical. The contract carries no set-aside designation, indicating it was...
- The Defense Logistics Agency (DLA) awarded a $1,103.38 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dorzolamide-Timolol eye drops (10ml), with an ultimate completion date of November 19, 2025. This delivery order, issued on November 18, 2025, represents a non-set-aside competitive award and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,486.64 to AmerisourceBergen Drug Corp for Dorzolamide-Timolol Eye Drops (10ml) on June 2, 2025, with an ultimate completion date of June 3, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a child order under AmerisourceBergen's larger prime contract vehicle with DLA. The product will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $3,495.11 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Dorzolamide-Timolol eye drops in 10mL units, with an ultimate completion date of September 15, 2025. This non-set-aside contract was competitively awarded on September 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a delivery order issued under the company's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of Dorzolamide-Timolol Eye Drops (10ML) with a contract ceiling value of $2,898.96. This competitively awarded, firm fixed-price delivery order is scheduled for completion by November 3, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation and represents a child contract under a larger vehicle...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FU059Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 20, 2025, for the supply of Dorzolamide-Timolol eye drops in 10ml quantities under a firm fixed-price contract valued at $4,762.14. This delivery order, which carries a completion date of November 21, 2025, represents a non-set-aside competitive award and serves as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical product will be performed and delivered from the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to supply a comprehensive range of pharmaceutical products and medical supplies, from generic medications to specialty therapeutics. This award exemplifies the routine delivery order activity under DLA's pharmaceutical prime vendor contracts, which enable flexible and efficient medical supply chain operations to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.8k | 11/20/25 |